Mar 30, 2021 5:10pm EDT ProPhase Labs Acquires Digital Covid Vaccination and Testing “Passport” Solution
Mar 15, 2021 8:30am EDT ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time
Feb 09, 2021 8:30am EST ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations
Feb 01, 2021 8:30am EST ProPhase Labs Exceeding Initial Goals as Covid-19 Lab Testing Business Ramps up
Jan 29, 2021 8:30am EST ProPhase Labs Announces Opening of Large CLIA Lab Covid Testing Facility in Garden City, New York
Jan 11, 2021 8:30am EST ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time
Jan 05, 2021 12:10pm EST ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
